GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Clinical trial NCT04731272 · RECRUITING
Trial details
- NCT number
- NCT04731272
- Sponsor
- University of Pennsylvania
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-16
- Primary completion
- 2027-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.